Adcock Ingram Holdings | AIP - Operating Expenses



Adcock Ingram Holdings reported ZAR4.23B in Operating Expenses for its fiscal semester ending in December of 2024.


Operating Expenses Change Date
Adcock Ingram Holdings ZAR 4.23B 196.72M Dec/2024
Alaunos Therapeutics USD 759K 391K Dec/2024
Aspen Pharmacare ZAR 17.18B 2.89B Dec/2024
Avita Medical AUD 28.36M 2.44M Dec/2024
Dianthus Therapeutics USD 35.12M 1.88M Jun/2025
Ionis Pharmaceuticals USD 312.21M 34.21M Jun/2025
IQVIA Holdings USD 3.46B 124M Jun/2025
Life Healthcare ZAR 11.97B 1.32B Sep/2024
Moderna USD 1.04B 113M Jun/2025
Netcare ZAR 11.5B 957M Sep/2024
Organon & Co USD 1.27B 144M Jun/2025
Revvity USD 629.52M 36.99M Jun/2025
Tectonic Therapeutic USD 22.33M 8.34M Jun/2025
Viatris USD 3.4B 2.88B Jun/2025
Xeris Pharmaceuticals USD 67.06M 8.64M Jun/2025